Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01269918 : A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain
PhasePhase 2/Phase 3
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

Patients who undergo general anesthesia for elective surgical excision of a brain tumor
with following specifications:

- Age: Older than 18

- Primary and redo cases will be included

- Duration of surgery not exceeding 6 hrs.

Exclusion Criteria:

- Patient refusal

- Emergency craniotomy

- Morbid obesity

- Uncontrolled hypertension - DBP more than 110

- Cardiac conduction defects

- Patients with chronic pain.
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT01269918      |      Link to official Clinicaltrials.gov listing
Locations
Cleveland, Ohio
Facility: The Cleveland Clinic Foundation
Investigator: Shobana Rajan, MD
Contact: Gretchen Upton, B. Psych Phone: 216-444-3289
Click HERE to send email to this center

Cleveland, Ohio
Facility: Cleveland Clinic Foundation
Investigator:
Contact: Gretchen Upton Phone: 216-444-3289
Click HERE to send email to this center




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites